| Line 939: | Line 939: | ||
===2017: [https://europa.eu/eurobarometer/surveys/detail/2146 Attitudes of Europeans towards tobacco and electronic cigarettes]=== | ===2017: [https://europa.eu/eurobarometer/surveys/detail/2146 Attitudes of Europeans towards tobacco and electronic cigarettes]=== | ||
*7.5 million EU citizens have quit smoking with nicotine vapes (“e-cigarettes”) | *7.5 million EU citizens have quit smoking with nicotine vapes (“e-cigarettes”) | ||
===2016: [https://www.bmj.com/content/354/bmj.i4645 Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends]=== | |||
*Changes in prevalence of e-cigarette use in England have been positively associated with the success rates of quit attempts. No clear association has been found between e-cigarette use and the rate of quit attempts or the use of other quitting aids, except for NRT obtained on prescription, where the association has been negative. | |||
*[https://www.bmj.com/content/bmj/354/bmj.i4645.full.pdf PDF Version] | |||
*Citation: Beard E, West R, Michie S, Brown J. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends BMJ 2016; 354 :i4645 doi:10.1136/bmj.i4645 | |||
*Acknowledgement: The Smoking Toolkit Study is currently primarily funded by Cancer Research UK (C1417/A14135; C36048/A11654; C44576/A19501), and has previously also been funded by Pfizer, GlaxoSmithKline, and the Department of Health. | |||
edits